N🟁N

The rise and fall of 23andMe

The article from MSN titled "The Rise and Fall of 23andMe" outlines the journey of the genetic testing company 23andMe, which was founded in 2006 by Anne Wojcicki, Linda Avey, and Paul Cusenza. Initially, 23andMe gained popularity by offering consumers insights into their ancestry and health predispositions through DNA analysis. The company experienced significant growth, attracting millions of users and partnerships with pharmaceutical giants like GlaxoSmithKline. However, its trajectory took a downturn due to several challenges: regulatory hurdles from the FDA which initially banned health-related genetic tests, privacy concerns over how genetic data was handled, and a massive data breach in 2023 affecting nearly 7 million users. Additionally, the company faced financial difficulties, with its valuation dropping significantly from a high of $1.5 billion to much lower figures, reflecting investor skepticism about its business model and future profitability. The narrative captures the highs of innovation in personal genomics and the lows of navigating complex regulatory landscapes and maintaining consumer trust in the digital age.

Read the Full Insider Article at:
[ https://www.msn.com/en-us/money/companies/the-rise-and-fall-of-23andme/ss-AA1sAWp9 ]